Coming from behind: Despite lagging in the vaccine race Curevac has twice in the last few weeks surpassed market valuation

Coming from behind: Despite lagging in the vaccine race Curevac has twice in the last few weeks surpassed market valuation of Deutsche Bank and now stands at about €16bn.
ft.com/content/c31597… https://t.co/jaVGbiVX9P

related posts